Player FM - Internet Radio Done Right
Checked 13d ago
تمت الإضافة منذ قبل three أعوام
المحتوى المقدم من Alice Watson. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Alice Watson أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Player FM - تطبيق بودكاست
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
EMJ GOLD: Pharma marketing, medical & more
وسم كل الحلقات كغير/(كـ)مشغلة
Manage series 3299609
المحتوى المقدم من Alice Watson. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Alice Watson أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm. Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
…
continue reading
286 حلقات
وسم كل الحلقات كغير/(كـ)مشغلة
Manage series 3299609
المحتوى المقدم من Alice Watson. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Alice Watson أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm. Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
…
continue reading
286 حلقات
كل الحلقات
×E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S09 E02: J&J's Martin Price on World Cancer Day 17:36
17:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب17:36![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Join Isabel and Jade as they present a special World Cancer Day 2025 edition of the podcast. They are joined by Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson. In this first instalment of the conversation, Martin and Jade discuss this year’s theme ‘United by Unique’, the increasing importance of real-world evidence in oncology and improving access to innovative cancer medicines. A little more on GOLD’s guest… Martin Price is Vice President for Health Economics, Market Access and Reimbursement in Europe, the Middle East and Africa, Johnson & Johnson, a role he has held for the past eight years. He leads the teams responsible for achieving optimal and accelerated market access, at a fair and value-based price, for Johnson & Johnson’s new products and indications. Prior to this, Price worked in Johnson & Johnson’s UK affiliate, latterly as director of external affairs, where he was responsible for market access, communications and government affairs. He joined Johnson & Johnson in 2001 from GlaxoSmithKline, where he began his career as senior health-outcomes manager.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S09 E01: Lundbeck’s Charl van Zyl on a new era in neurology 22:23
22:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب22:23![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
The EMJ GOLD podcast is back for a new season! In the first episode of Season 9, the team are welcomed by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders, making this the 'decade of the brain', and how industry can do more to support patients living brain conditions. Together, Charl and Isabel explore his career journey in the pharmaceutical industry, Lundbeck’s plans for the future, the role of digital health technology and much more. A little more on EMJ GOLD’s guest... Charl van Zyl joined Lundbeck as President and CEO in September 2023. He brings more than 23 years of experience from commercial international management roles within the pharmaceutical industry, most recently in the field of immunology and neurology from UCB where he served as Executive Vice President and Head of Neurology globally, responsible for corporate activities in Europe and international markets. Charl is British and holds a degree in Medical Biochemistry from the University of Cape Town, South Africa. He has lived and worked in South Africa, United States, Japan, Switzerland, Belgium and now Denmark.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year’s predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead. The line-up includes Jennifer Schranz of Ipsen, Mercedes Diz of Almirall and EMJ’s own Dr Jonathan Sackier - all of whom share their predictions in their areas of expertise. A little more on GOLD’s guests… Jennifer Schranz is the Senior Vice President, Global Head of Rare Diseases at Ipsen, where she oversees the Rare Diseases therapy area with a focus on R&D strategy and execution. During her time at the business, she has led talented teams of scientists and fostered strong internal collaborations within the company, leveraging her clinical development expertise to advance Ipsen’s vision of addressing challenging rare diseases. Mercedes Diz has over 20 years’ experience in the pharmaceutical industry, having graduated with a degree in Biochemistry and Molecular Biology from the Autonomous University of Madrid. She has worked in a number of different pharmaceutical companies, from J&J to Pfizer, and is also a keen member of the Healthcare Businesswomen’s Association. At Almirall, she leads portfolio strategy and commercial innovation for global brands, new products and digital and cultural transformation. Dr Jonathan Sackier is Chairman at EMJ and the host of the EMJ podcast, where he utilises his experience as a physician to discuss the latest breakthroughs and challenges in the medical field with fellow practitioners and experts. Jonathan is a founding partner of many start-ups in the medical technology space and created the world’s first operating room robot.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 Bonus episode: Pharma review of the year 2024 23:43
23:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:43![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
As 2024 comes to a close, it's time to look back on a year in the pharmaceutical industry. In this final episode of the year, Isabel and Jade are joined by three former guest to reflect on the pivotal moments that defined the past 12 months. They are joined by Jennifer Schranz from Ipsen, Martina Dempsey from Astellas and Elias Revonta, CEO of Orcason, who all return to the podcast to share their insights. Together, they’ll discuss the major trends, challenges and breakthroughs that shaped 2024, including advancements in oncology, gene therapy, rare diseases and the growing role of AI. A little more on EMJ GOLD's guests... Jennifer Schranz is the Senior Vice President, Global Head of Rare Diseases at Ipsen, where she oversees the Rare Diseases therapy area with a focus on R&D strategy and execution. During her time at the business she has led talented teams of scientists and fostered strong internal collaborations within the company, leveraging her clinical development expertise to advance Ipsen’s vision of addressing challenging rare diseases. Martina Dempsey is the Vice President of Commercial Strategy & Operations at Astellas Europe, having worked with the business since 2014 in her home country of Ireland. In addition to her role at the pharma company, she also acts as a Board Member for the Irish Pharmaceutical Healthcare Association. Prior to her time at Astellas, she spent 13 years at GSK in various roles including in the regulatory affairs and business transformation sectors. Elias Revonta is the Founder and CEO, Orcason Medical, where he is supported by a strong background in the medical device industry – spanning over 20 years in various leadership roles from sales to product development. He is passionate about transforming and democratising healthcare with modern and easy-to-use diagnostic tools that serve all demographics.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S08 E10: Bayer’s Dr Cecilia Caetano on making space for menopause 26:56
26:56
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب26:56![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this final episode of the season, Isabel discusses how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Head, Global Medical Affairs, Women’s Health, Bayer. Menopause affects over 50% of the world’s population, but its symptoms and effects are often misunderstood or ignored. Find out how industry can help by equipping not only HCPs but also women with the knowledge and awareness to manage menopause on an individual level, debunking the myths and prejudices surrounding the topic and much more.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 Season 8 highlights: GOLD Medal Moments 13:06
13:06
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب13:06![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Season 8 is almost over, but before we release our finale episode, why not take a listen to some of our favourite moments from the last couple of months? From an insight into why Gen Z might be turning their sails towards the pharmaceutical industry, to a call for a better understanding of HIV stigma, there’s plenty to discover in this season’s GOLD Medal Moments.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S08 E09: World AMR Awareness Week with Orcason Medical’s Elias Revonta 24:23
24:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب24:23![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this episode of the EMJ GOLD podcast, Jade and Isabel explore one of the most urgent global health issues: antimicrobial resistance (AMR). As part of World AMR Awareness Week, they are highlighting this year’s theme ‘Educate. Advocate. Act now’. Joining the conversation is Elias Revonta, Founder and CEO, Orcason Medical, who shares his vision for tackling AMR through groundbreaking medical technology. Orcason Medical is pioneering point-of-care devices for ear, nose and throat conditions to address the overprescription of antibiotics—a vital measure in the fight against AMR. A little more on GOLD’s guest… Elias Revonta is the Founder and CEO, Orcason Medical, where he is supported by a strong background in the medical device industry – spanning over 20 years in various leadership roles from sales to product development. He is passionate about transforming and democratising healthcare with modern and easy-to-use diagnostic tools that serve all demographics. With a mission to combat the rise of AMR, his goal is to protect the power of antibiotics and improve the lives of millions of patients by enabling smarter, safer healthcare solutions.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S08 E08: Alfasigma’s Patrick Oliver on the company’s new chapter in the UK 20:31
20:31
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب20:31![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this episode, Isabel welcomes Patrick Oliver, General Manager for the UK and Ireland at Alfasigma, to explore the company’s exciting entry into the UK market and the evolving landscape of healthcare in the country. In the conversation, Patrick brings his wealth of industry experience to share his vision for Alfasigma’s future, the potential he sees in the UK healthcare market and the unique challenges ahead. They also delve into Lord Darzi’s report on the NHS, examining its implications for healthcare reform and innovation. A little more on GOLD’s guest… Patrick Oliver is Alfasigma’s General Manager for the UK & Ireland, a role he’s held since the company’s launch in the UK in early 2024. He has 36 years’ experience in the industry, with 16 years specifically in market access. Prior to joining Alfasigma, Patrick worked in market access for a number of large pharmaceutical companies including Johnson & Johnson, AbbVie and Abbott.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S08 E07: What should marketing and medical affairs invest in for Q4? 9:17
9:17
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب9:17![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
As 2024 draws to a close, what should pharma teams be focusing their budgets on for the final quarter of the year? Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024. As teams finalise their budgets and plan for the final quarter and year ahead, this conversation brings insights into how strategies like personalised engagement, thought leadership and interactive, on-demand content are making an impact. With real-life examples, learn about the tools you can invest in to end the year on a high.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S08 E06: Ipsen’s Jennifer Schranz on rethinking rare disease for women 23:41
23:41
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:41![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this new episode, the team welcomes Jennifer Schranz, Senior Vice President, Global Head of Rare Diseases, Ipsen, to investigate the burden faced by women with rare diseases. Together, Jennifer and Jade discuss how the industry can address challenging rare diseases and making a meaningful impact on patients’ lives, the double jeopardy that women with rare diseases face, recent breakthroughs in the space and much more.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S08 E05: ARS' Richard Lowenthal on his mission to transform allergy care 21:04
21:04
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب21:04![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In the latest episode of our podcast, we welcome Richard Lowenthal, CEO, ARS Pharmaceuticals, to explore the company’s mission to address unmet needs in allergy care. During the conversation, Richard shares insights into his early career at the FDA and the regulatory challenges he faced in bringing ARS’s new nasal spray to treat severe allergic reactions to market. He also discusses the future direction of the company and much more. A little more on EMJ GOLD’s guest… Richard Lowenthal is the co-founder, President, and CEO, ARS Pharmaceuticals, with a leadership role since the company’s inception in 2015. Before ARS, he founded Pacific-Link Regulatory Consulting, where he contributed to the development of their diazepam nasal spray. Richard’s extensive background includes senior roles at Cadence Pharmaceuticals, Maxim Pharmaceuticals and Janssen Research Foundation, as well as work as a chemist at the FDA. He holds an M.Sc. in organic chemistry and an MSEL and has chaired the American Association of Pharmaceutical Scientists.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S08 E04: Astellas’ Martina Dempsey on achieving equal footing for women in pharma 29:07
29:07
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب29:07![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In the latest episode, Jade sits down with Martina Dempsey, Vice President of Commercial Strategy and Operations at Astellas Europe, to discuss empowering women in the pharmaceutical industry. They explore how pharma meets the needs and values of young graduates, the ongoing challenges women face in securing leadership roles, the critical impact of mentorship on career development and much more.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S08 E03: World Mental Health Day with Boehringer Ingelheim’s Nedim Pipic 24:24
24:24
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب24:24![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this episode, Isabel is joined by Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim, to mark World Mental Health Day on 10 October 2024. Their conversation dives into the unique challenges faced by those living with serious mental illnesses, the impact of media representation and the role pharma can play in transforming treatment and quality of life for these patients. Central to their discussion is the importance of amplifying lived experiences, a key focus of Boehringer’s new campaign, Schizophrenia in Real Life: Stories of Challenges, Resilience, and Hope . The campaign aims to build greater understanding and acceptance of the condition by highlighting the strength and resilience of those living with it.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S08 E02: ViiV Healthcare’s Jean-Bernard Simeon on ending the HIV epidemic 27:41
27:41
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب27:41![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
This week, Jean-Bernard Simeon, Senior Vice President and Head, ViiV Healthcare Europe, sits down with the EMJ GOLD team to share his thoughts on the current landscape for patients with HIV in Europe. Together, JB and Jade explore the UNAIDS roadmap to end the HIV epidemic by 2030, the barriers faced by people living with HIV in Europe, stigmas still surrounding the condition and much more.…
E
EMJ GOLD: Pharma marketing, medical & more
![EMJ GOLD: Pharma marketing, medical & more podcast artwork](/static/images/64pixel.png)
1 S08 E01: Moderna’s Chantal Friebertshäuser on improving vaccine confidence 25:48
25:48
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب25:48![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
The EMJ GOLD podcast is back! In the first episode of season 8, Jade sits down with Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna, to discuss how Europe can combat the recent erosion of trust in vaccines. Together, the two explore the role of governments in addressing vaccine hesitancy, improving vaccine education amongst various groups, how a culture of collaboration can improve the current vaccine landscape and much more.…
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.